Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

Kjeld Schmiegelow, Mats Heyman, Jon Kristinsson, Ulla B Mogensen, Susanne Rosthøj, Kim Vettenranta, Finn Wesenberg, Ulla Saarinen-Pihkala, Nordic Society of Paediatric Haematology and Oncology (NOPHO)

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study'. Together they form a unique fingerprint.

Medicine & Life Sciences